- REPORT SUMMARY
- TABLE OF CONTENTS
-
This report offers an overview of the market trends, drivers, and barriers with respect to the USA Bio-pharma market. It also provides a detailed overview of the market of different regions across West USA, South USA, Middle West USA, Northeast USA. The report deeply analyzes type and application in the USA Bio-pharma market. Detailed analysis of key players, along with key growth strategies adopted by Bio-pharma industry, the PEST and SWOT analysis are also included. In short, the report will provide a comprehensive view of the industry's development and features.
By Player:
Johnson & Johnson Services
Bristol-Myers Squibb Company
AstraZeneca PLC
Merck & Co, Inc
AbbVie
Bayer AG
Novartis AG GlaxoSmithKline Plc
F Hoffmann-La Roche AG
Abbott Laboratories
Sanofi, Amgen
Eli Lilly and Company
Pfizer
Biogen Idec
By Type:
Monoclonal Antibodies
Recombinant Proteins
Granulocyte-Colony Stimulating Factor (G-CSF)
Interferons
Recombinant Human Insulin
Erythropoietin
Vaccines
Growth Hormones
Purified Proteins
Others
By End-User:
Metabolic Disorders
Oncology
Neurological Disorders
Cardiovascular Diseases
Inflammatory and Infectious Diseases
Others
By Region:
-
West USA
-
South USA
-
Middle West USA
-
Northeast USA
TABLE OF CONTENT
1 Report Overview
-
1.1 Product Definition and Scope
-
1.2 PEST (Political, Economic, Social and Technological) Analysis of Bio-pharma Market
-
1.3 Market Segment by Type
-
1.3.1 USA Bio-pharma Market Size and Growth Rate of Monoclonal Antibodies from 2016 to 2027
-
1.3.2 USA Bio-pharma Market Size and Growth Rate of Recombinant Proteins from 2016 to 2027
-
1.3.3 USA Bio-pharma Market Size and Growth Rate of Granulocyte-Colony Stimulating Factor (G-CSF) from 2016 to 2027
-
1.3.4 USA Bio-pharma Market Size and Growth Rate of Interferons from 2016 to 2027
-
1.3.5 USA Bio-pharma Market Size and Growth Rate of Recombinant Human Insulin from 2016 to 2027
-
1.3.6 USA Bio-pharma Market Size and Growth Rate of Erythropoietin from 2016 to 2027
-
1.3.7 USA Bio-pharma Market Size and Growth Rate of Vaccines from 2016 to 2027
-
1.3.8 USA Bio-pharma Market Size and Growth Rate of Growth Hormones from 2016 to 2027
-
1.3.9 USA Bio-pharma Market Size and Growth Rate of Purified Proteins from 2016 to 2027
-
1.3.10 USA Bio-pharma Market Size and Growth Rate of Others from 2016 to 2027
-
1.4 Market Segment by Application
-
1.4.1 USA Bio-pharma Market Size and Growth Rate of Metabolic Disorders from 2016 to 2027
-
1.4.2 USA Bio-pharma Market Size and Growth Rate of Oncology from 2016 to 2027
-
1.4.3 USA Bio-pharma Market Size and Growth Rate of Neurological Disorders from 2016 to 2027
-
1.4.4 USA Bio-pharma Market Size and Growth Rate of Cardiovascular Diseases from 2016 to 2027
-
1.4.5 USA Bio-pharma Market Size and Growth Rate of Inflammatory and Infectious Diseases from 2016 to 2027
-
1.4.6 USA Bio-pharma Market Size and Growth Rate of Others from 2016 to 2027
-
1.5 Market Segment by Regions
-
1.5.1 West USA Bio-pharma Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.2 South USA Bio-pharma Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.3 Middle West USA Bio-pharma Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.4 Northeast USA Bio-pharma Consumption Market Size and Growth Rate from 2016 to 2027
2 Market Trends and Competitive Landscape
-
2.1 Market Trends and Dynamics
-
2.1.1 Market Challenges and Restraints
-
2.1.2 Market Opportunities and Potentials
-
2.1.3 Mergers and Acquisitions
-
2.2 Competitive Landscape Analysis
-
2.2.1 Industrial Concentration Analysis
-
2.2.2 Porter's Five Forces Analysis of the Industry
-
2.2.3 SWOT Analysis for New Entrants
-
2.3 Coronavirus (COVID-19) Distribution and its Impact on the Industry
3 Segmentation of Bio-pharma Market by Types
-
3.1 Products Development Trends of Different Types
-
3.2 Products Types of Major Vendors
-
3.3 Competitive Landscape Analysis of Different Types
-
3.4 Market Size of Bio-pharma by Major Types
-
3.4.1 Market Size and Growth Rate of Monoclonal Antibodies
-
3.4.2 Market Size and Growth Rate of Recombinant Proteins
-
3.4.3 Market Size and Growth Rate of Granulocyte-Colony Stimulating Factor (G-CSF)
-
3.4.4 Market Size and Growth Rate of Interferons
-
3.4.5 Market Size and Growth Rate of Recombinant Human Insulin
-
3.4.6 Market Size and Growth Rate of Erythropoietin
-
3.4.7 Market Size and Growth Rate of Vaccines
-
3.4.8 Market Size and Growth Rate of Growth Hormones
-
3.4.9 Market Size and Growth Rate of Purified Proteins
-
3.4.10 Market Size and Growth Rate of Others
4 Segmentation of Bio-pharma Market by End-Users
-
4.1 Downstream Client Analysis by End-Users
-
4.2 Competitive Landscape Analysis of Different End-Users
-
4.3 Market Potential Analysis of Different End-Users
-
4.4 Market Size of Bio-pharma by Major End-Users
-
4.4.1 Market Size and Growth Rate of Bio-pharma in Metabolic Disorders
-
4.4.2 Market Size and Growth Rate of Bio-pharma in Oncology
-
4.4.3 Market Size and Growth Rate of Bio-pharma in Neurological Disorders
-
4.4.4 Market Size and Growth Rate of Bio-pharma in Cardiovascular Diseases
-
4.4.5 Market Size and Growth Rate of Bio-pharma in Inflammatory and Infectious Diseases
-
4.4.6 Market Size and Growth Rate of Bio-pharma in Others
5 Market Analysis by Regions
-
5.1 USA Bio-pharma Production Analysis by Regions
-
5.2 USA Bio-pharma Consumption Analysis by Regions
-
5.3 Coronavirus (COVID-19) Impact on USA Economy
6 West USA Bio-pharma Landscape Analysis
-
6.1 West USA Bio-pharma Landscape Analysis by Major Types
-
6.2 West USA Bio-pharma Landscape Analysis by Major End-Users
7 South USA Bio-pharma Landscape Analysis
-
7.1 South USA Bio-pharma Landscape Analysis by Major Types
-
7.2 South USA Bio-pharma Landscape Analysis by Major End-Users
8 Middle West USA Bio-pharma Landscape Analysis
-
8.1 Middle West USA Bio-pharma Landscape Analysis by Major Types
-
8.2 Middle West USA Bio-pharma Landscape Analysis by Major End-Users
9 Northeast USA Bio-pharma Landscape Analysis
-
9.1 Northeast USA Bio-pharma Landscape Analysis by Major Types
-
9.2 Northeast USA Bio-pharma Landscape Analysis by Major End-Users
10 Major Players Profiles
-
10.1 Johnson & Johnson Services
-
10.1.1 Johnson & Johnson Services Company Profile and Recent Development
-
10.1.2 Market Performance
-
10.1.3 Product and Service Introduction
-
10.2 Bristol-Myers Squibb Company
-
10.2.1 Bristol-Myers Squibb Company Company Profile and Recent Development
-
10.2.2 Market Performance
-
10.2.3 Product and Service Introduction
-
10.3 AstraZeneca PLC
-
10.3.1 AstraZeneca PLC Company Profile and Recent Development
-
10.3.2 Market Performance
-
10.3.3 Product and Service Introduction
-
10.4 Merck & Co, Inc
-
10.4.1 Merck & Co, Inc Company Profile and Recent Development
-
10.4.2 Market Performance
-
10.4.3 Product and Service Introduction
-
10.5 AbbVie
-
10.5.1 AbbVie Company Profile and Recent Development
-
10.5.2 Market Performance
-
10.5.3 Product and Service Introduction
-
10.6 Bayer AG
-
10.6.1 Bayer AG Company Profile and Recent Development
-
10.6.2 Market Performance
-
10.6.3 Product and Service Introduction
-
10.7 Novartis AG GlaxoSmithKline Plc
-
10.7.1 Novartis AG GlaxoSmithKline Plc Company Profile and Recent Development
-
10.7.2 Market Performance
-
10.7.3 Product and Service Introduction
-
10.8 F Hoffmann-La Roche AG
-
10.8.1 F Hoffmann-La Roche AG Company Profile and Recent Development
-
10.8.2 Market Performance
-
10.8.3 Product and Service Introduction
-
10.9 Abbott Laboratories
-
10.9.1 Abbott Laboratories Company Profile and Recent Development
-
10.9.2 Market Performance
-
10.9.3 Product and Service Introduction
-
10.10 Sanofi, Amgen
-
10.10.1 Sanofi, Amgen Company Profile and Recent Development
-
10.10.2 Market Performance
-
10.10.3 Product and Service Introduction
-
10.11 Eli Lilly and Company
-
10.11.1 Eli Lilly and Company Company Profile and Recent Development
-
10.11.2 Market Performance
-
10.11.3 Product and Service Introduction
-
10.12 Pfizer
-
10.12.1 Pfizer Company Profile and Recent Development
-
10.12.2 Market Performance
-
10.12.3 Product and Service Introduction
-
10.13 Biogen Idec
-
10.13.1 Biogen Idec Company Profile and Recent Development
-
10.13.2 Market Performance
-
10.13.3 Product and Service Introduction
The List of Tables and Figures
-
Figure Product Picture
-
Figure USA Bio-pharma Market Size and Growth Rate of Monoclonal Antibodies from 2016 to 2027
-
Figure USA Bio-pharma Market Size and Growth Rate of Recombinant Proteins from 2016 to 2027
-
Figure USA Bio-pharma Market Size and Growth Rate of Granulocyte-Colony Stimulating Factor (G-CSF) from 2016 to 2027
-
Figure USA Bio-pharma Market Size and Growth Rate of Interferons from 2016 to 2027
-
Figure USA Bio-pharma Market Size and Growth Rate of Recombinant Human Insulin from 2016 to 2027
-
Figure USA Bio-pharma Market Size and Growth Rate of Erythropoietin from 2016 to 2027
-
Figure USA Bio-pharma Market Size and Growth Rate of Vaccines from 2016 to 2027
-
Figure USA Bio-pharma Market Size and Growth Rate of Growth Hormones from 2016 to 2027
-
Figure USA Bio-pharma Market Size and Growth Rate of Purified Proteins from 2016 to 2027
-
Figure USA Bio-pharma Market Size and Growth Rate of Others from 2016 to 2027
-
Figure Market Share by Type in 2016
-
Figure Market Share by Type in 2020
-
Figure Market Share by Type in 2027
-
Figure USA Bio-pharma Market Size and Growth Rate of Metabolic Disorders from 2016 to 2027
-
Figure USA Bio-pharma Market Size and Growth Rate of Oncology from 2016 to 2027
-
Figure USA Bio-pharma Market Size and Growth Rate of Neurological Disorders from 2016 to 2027
-
Figure USA Bio-pharma Market Size and Growth Rate of Cardiovascular Diseases from 2016 to 2027
-
Figure USA Bio-pharma Market Size and Growth Rate of Inflammatory and Infectious Diseases from 2016 to 2027
-
Figure USA Bio-pharma Market Size and Growth Rate of Others from 2016 to 2027
-
Figure Market Share by End-User in 2016
-
Figure Market Share by End-User in 2020
-
Figure Market Share by End-User in 2027
-
Figure West USA Bio-pharma Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure South USA Bio-pharma Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure Middle West USA Bio-pharma Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure Northeast USA Bio-pharma Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure Development Trends and Industry Dynamics of Bio-pharma Industry
-
Figure Market Challenges and Restraints
-
Figure Market Opportunities and Potentials
-
Table Mergers and Acquisition
-
Figure Market Share of TOP 3 Players in 2019
-
Figure Market Share of TOP 5 Players in 2019
-
Figure Market Share of TOP 6 Players from 2016 to 2020
-
Figure Porter's Five Forces Analysis
-
Figure New Entrant SWOT Analysis
-
Figure Coronavirus (COVID-19) Distribution Map of USA
-
Table Coronavirus (COVID-19) Impact on the Industry
-
Figure Specifications of Different Types of Bio-pharma
-
Figure Development Trends of Different Types
-
Table Products Types of Major Vendors
-
Figure Competitive Landscape Analysis of Different Types
-
Table Consumption of Bio-pharma by Different Types from 2016 to 2027
-
Table Consumption Share of Bio-pharma by Different Types from 2016 to 2027
-
Figure Market Size and Growth Rate of Monoclonal Antibodies
-
Figure Market Size and Growth Rate of Recombinant Proteins
-
Figure Market Size and Growth Rate of Granulocyte-Colony Stimulating Factor (G-CSF)
-
Figure Market Size and Growth Rate of Interferons
-
Figure Market Size and Growth Rate of Recombinant Human Insulin
-
Figure Market Size and Growth Rate of Erythropoietin
-
Figure Market Size and Growth Rate of Vaccines
-
Figure Market Size and Growth Rate of Growth Hormones
-
Figure Market Size and Growth Rate of Purified Proteins
-
Figure Market Size and Growth Rate of Others
-
Table Downstream Client Analysis by End-Users
-
Figure Competitive Landscape Analysis of Different End-Users
-
Table Market Potential Analysis of Different End-Users
-
Figure Consumption of Bio-pharma by Different End-Users from 2016 to 2027
-
Table Consumption Share of Bio-pharma by Different End-Users from 2016 to 2027
-
Figure Market Size and Growth Rate of Metabolic Disorders
-
Figure Market Size and Growth Rate of Oncology
-
Figure Market Size and Growth Rate of Neurological Disorders
-
Figure Market Size and Growth Rate of Cardiovascular Diseases
-
Figure Market Size and Growth Rate of Inflammatory and Infectious Diseases
-
Figure Market Size and Growth Rate of Others
-
Table USA Bio-pharma Production by Regions
-
Table USA Bio-pharma Production Share by Regions
-
Figure USA Bio-pharma Production Share by Regions in 2016
-
Figure USA Bio-pharma Production Share by Regions in 2021
-
Figure USA Bio-pharma Production Share by Regions in 2027
-
Table USA Bio-pharma Consumption by Regions
-
Table USA Bio-pharma Consumption Share by Regions
-
Figure USA Bio-pharma Consumption Share by Regions in 2016
-
Figure USA Bio-pharma Consumption Share by Regions in 2021
-
Figure USA Bio-pharma Consumption Share by Regions in 2027
-
Table West USA Bio-pharma Consumption by Types from 2016 to 2027
-
Table West USA Bio-pharma Consumption Share by Types from 2016 to 2027
-
Figure West USA Bio-pharma Consumption Share by Types in 2016
-
Figure West USA Bio-pharma Consumption Share by Types in 2021
-
Figure West USA Bio-pharma Consumption Share by Types in 2027
-
Table West USA Bio-pharma Consumption by End-Users from 2016 to 2027
-
Table West USA Bio-pharma Consumption Share by End-Users from 2016 to 2027
-
Figure West USA Bio-pharma Consumption Share by End-Users in 2016
-
Figure West USA Bio-pharma Consumption Share by End-Users in 2021
-
Figure West USA Bio-pharma Consumption Share by End-Users in 2027
-
Table South USA Bio-pharma Consumption by Types from 2016 to 2027
-
Table South USA Bio-pharma Consumption Share by Types from 2016 to 2027
-
Figure South USA Bio-pharma Consumption Share by Types in 2016
-
Figure South USA Bio-pharma Consumption Share by Types in 2021
-
Figure South USA Bio-pharma Consumption Share by Types in 2027
-
Table South USA Bio-pharma Consumption by End-Users from 2016 to 2027
-
Table South USA Bio-pharma Consumption Share by End-Users from 2016 to 2027
-
Figure South USA Bio-pharma Consumption Share by End-Users in 2016
-
Figure South USA Bio-pharma Consumption Share by End-Users in 2021
-
Figure South USA Bio-pharma Consumption Share by End-Users in 2027
-
Table Middle West USA Bio-pharma Consumption by Types from 2016 to 2027
-
Table Middle West USA Bio-pharma Consumption Share by Types from 2016 to 2027
-
Figure Middle West USA Bio-pharma Consumption Share by Types in 2016
-
Figure Middle West USA Bio-pharma Consumption Share by Types in 2021
-
Figure Middle West USA Bio-pharma Consumption Share by Types in 2027
-
Table Middle West USA Bio-pharma Consumption by End-Users from 2016 to 2027
-
Table Middle West USA Bio-pharma Consumption Share by End-Users from 2016 to 2027
-
Figure Middle West USA Bio-pharma Consumption Share by End-Users in 2016
-
Figure Middle West USA Bio-pharma Consumption Share by End-Users in 2021
-
Figure Middle West USA Bio-pharma Consumption Share by End-Users in 2027
-
Table Northeast USA Bio-pharma Consumption by Types from 2016 to 2027
-
Table Northeast USA Bio-pharma Consumption Share by Types from 2016 to 2027
-
Figure Northeast USA Bio-pharma Consumption Share by Types in 2016
-
Figure Northeast USA Bio-pharma Consumption Share by Types in 2021
-
Figure Northeast USA Bio-pharma Consumption Share by Types in 2027
-
Table Northeast USA Bio-pharma Consumption by End-Users from 2016 to 2027
-
Table Northeast USA Bio-pharma Consumption Share by End-Users from 2016 to 2027
-
Figure Northeast USA Bio-pharma Consumption Share by End-Users in 2016
-
Figure Northeast USA Bio-pharma Consumption Share by End-Users in 2021
-
Figure Northeast USA Bio-pharma Consumption Share by End-Users in 2027
-
Table Company Profile and Development Status of Johnson & Johnson Services
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Johnson & Johnson Services
-
Figure Sales and Growth Rate Analysis of Johnson & Johnson Services
-
Figure Revenue and Market Share Analysis of Johnson & Johnson Services
-
Table Product and Service Introduction of Johnson & Johnson Services
-
Table Company Profile and Development Status of Bristol-Myers Squibb Company
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Bristol-Myers Squibb Company
-
Figure Sales and Growth Rate Analysis of Bristol-Myers Squibb Company
-
Figure Revenue and Market Share Analysis of Bristol-Myers Squibb Company
-
Table Product and Service Introduction of Bristol-Myers Squibb Company
-
Table Company Profile and Development Status of AstraZeneca PLC
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of AstraZeneca PLC
-
Figure Sales and Growth Rate Analysis of AstraZeneca PLC
-
Figure Revenue and Market Share Analysis of AstraZeneca PLC
-
Table Product and Service Introduction of AstraZeneca PLC
-
Table Company Profile and Development Status of Merck & Co, Inc
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Merck & Co, Inc
-
Figure Sales and Growth Rate Analysis of Merck & Co, Inc
-
Figure Revenue and Market Share Analysis of Merck & Co, Inc
-
Table Product and Service Introduction of Merck & Co, Inc
-
Table Company Profile and Development Status of AbbVie
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of AbbVie
-
Figure Sales and Growth Rate Analysis of AbbVie
-
Figure Revenue and Market Share Analysis of AbbVie
-
Table Product and Service Introduction of AbbVie
-
Table Company Profile and Development Status of Bayer AG
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Bayer AG
-
Figure Sales and Growth Rate Analysis of Bayer AG
-
Figure Revenue and Market Share Analysis of Bayer AG
-
Table Product and Service Introduction of Bayer AG
-
Table Company Profile and Development Status of Novartis AG GlaxoSmithKline Plc
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Novartis AG GlaxoSmithKline Plc
-
Figure Sales and Growth Rate Analysis of Novartis AG GlaxoSmithKline Plc
-
Figure Revenue and Market Share Analysis of Novartis AG GlaxoSmithKline Plc
-
Table Product and Service Introduction of Novartis AG GlaxoSmithKline Plc
-
Table Company Profile and Development Status of F Hoffmann-La Roche AG
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of F Hoffmann-La Roche AG
-
Figure Sales and Growth Rate Analysis of F Hoffmann-La Roche AG
-
Figure Revenue and Market Share Analysis of F Hoffmann-La Roche AG
-
Table Product and Service Introduction of F Hoffmann-La Roche AG
-
Table Company Profile and Development Status of Abbott Laboratories
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Abbott Laboratories
-
Figure Sales and Growth Rate Analysis of Abbott Laboratories
-
Figure Revenue and Market Share Analysis of Abbott Laboratories
-
Table Product and Service Introduction of Abbott Laboratories
-
Table Company Profile and Development Status of Sanofi, Amgen
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Sanofi, Amgen
-
Figure Sales and Growth Rate Analysis of Sanofi, Amgen
-
Figure Revenue and Market Share Analysis of Sanofi, Amgen
-
Table Product and Service Introduction of Sanofi, Amgen
-
Table Company Profile and Development Status of Eli Lilly and Company
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Eli Lilly and Company
-
Figure Sales and Growth Rate Analysis of Eli Lilly and Company
-
Figure Revenue and Market Share Analysis of Eli Lilly and Company
-
Table Product and Service Introduction of Eli Lilly and Company
-
Table Company Profile and Development Status of Pfizer
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Pfizer
-
Figure Sales and Growth Rate Analysis of Pfizer
-
Figure Revenue and Market Share Analysis of Pfizer
-
Table Product and Service Introduction of Pfizer
-
Table Company Profile and Development Status of Biogen Idec
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Biogen Idec
-
Figure Sales and Growth Rate Analysis of Biogen Idec
-
Figure Revenue and Market Share Analysis of Biogen Idec
-
Table Product and Service Introduction of Biogen Idec
-